AbCellera Biologics Inc.
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
31.58 |
22.62 |
64.69 |
83.10 |
143.25 |
202.44 |
| Przychód Δ r/r |
0.00% |
-28.37% |
185.98% |
28.46% |
72.38% |
41.32% |
| Przychód (min) |
28.75 |
11.75 |
29.52 |
80.71 |
74.33 |
105.04 |
| Przychód (max) |
36.12 |
46.81 |
179.47 |
85.49 |
329.68 |
465.90 |
| EBITDA (średnia) |
-0.43 |
-0.31 |
-0.88 |
-1.13 |
-1.94 |
-2.74 |
| EBIT (średnia) |
-1.29 |
-0.93 |
-2.65 |
-3.40 |
-5.86 |
-8.28 |
| EBIT % |
-4.09% |
-4.09% |
-4.09% |
-4.09% |
-4.09% |
-4.09% |
| Zysk netto (średni) |
-167.87 |
-174.26 |
-163.56 |
-117.30 |
-35.32 |
14.72 |
| Zysk netto % |
-531.54% |
-770.36% |
-252.84% |
-141.16% |
-24.66% |
7.27% |
| EPS (średnia) |
-0.59 |
-0.59 |
-0.46 |
-0.48 |
-0.12 |
0.05 |
| Liczba analityków (Przychody) |
9 |
8 |
8 |
5 |
1 |
2 |
| Liczba analityków (EPS) |
6 |
5 |
5 |
4 |
3 |
2 |
| symbol |
ABCL |
ABCL |
ABCL |
ABCL |
ABCL |
ABCL |